Iti Pharma And Healthcare Fund Overview
Category Sectoral/ Thematic
BMSMONEY Rank 5
Rating
Growth Option 07-03-2025
NAV ₹15.03(R) -0.08% ₹16.09(D) -0.07%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 11.9% 19.07% -% -% -%
Direct 14.01% 21.51% -% -% -%
Benchmark
SIP (XIRR) Regular -3.82% 19.99% -% -% -%
Direct -1.91% 22.42% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.6 0.3 0.65 5.89% 0.11
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.14% -24.78% -16.32% 0.87 11.67%
Top Sectoral/ Thematic
Fund Name Rank Rating
Icici Prudential India Opportunities Fund 1
Icici Prudential Exports And Services Fund 2
Franklin India Opportunities Fund 3
ICICI Prudential Business Cycle Fund 4
ITI Pharma and Healthcare Fund 5

NAV Date: 07-03-2025

Scheme Name NAV Rupee Change Percent Change
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option 15.03
-0.0100
-0.0800%
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 15.03
-0.0100
-0.0800%
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option 16.09
-0.0100
-0.0700%
ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option 16.09
-0.0100
-0.0700%

Review Date: 07-03-2025

ITI Pharma and Healthcare Fund has shown very good performance in the Sectoral/ Thematic Fund category. The fund has rank of 3 out of 20 funds in the category. The fund has delivered return of 11.9% in 1 year and 19.07% in 3 years. The category average for the same periods is 2.42% and 16.74% respectively, which shows poor return performance of fund in the category. The fund has exhibited standard deviation of 16.14, VaR of -24.78, Average Drawdown of -8.38, Semi Deviation of 11.67 and Max Drawdown of -16.32. The category average for the same parameters is 14.88, -19.83, -7.18, 10.65 and -17.78 respectively. The fund has high risk in the category.
  • standard deviation of 16.14 and based on VaR one can expect to lose more than -24.78% of current value of fund in one year.
  • Sharpe ratio of the fund is 0.6 which shows good performance of fund in the sectoral/ thematic fund category.
  • The fund has R-square of 0.6, Beta of 0.87 and Jensen's Alpha of 5.89% which exhibit very good performance in the sectoral/ thematic fund category .


    • Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Iti Pharma And Healthcare Fund NAV Regular Growth Iti Pharma And Healthcare Fund NAV Direct Growth
    07-03-2025 15.0273 16.0886
    06-03-2025 15.0388 16.1001
    05-03-2025 14.9066 15.9578
    04-03-2025 14.6482 15.6804
    03-03-2025 14.552 15.5766
    28-02-2025 14.584 15.6084
    27-02-2025 14.8459 15.8879
    25-02-2025 14.9994 16.0506
    24-02-2025 15.0064 16.0572
    21-02-2025 15.081 16.1345
    20-02-2025 15.2884 16.3556
    19-02-2025 15.1605 16.218
    18-02-2025 15.1127 16.166
    17-02-2025 15.1999 16.2584
    14-02-2025 15.072 16.1191
    13-02-2025 15.5085 16.585
    12-02-2025 15.4165 16.4859
    11-02-2025 15.5032 16.5777
    10-02-2025 15.9618 17.0672
    07-02-2025 16.3323 17.4607

    Fund Launch Date: 17/Nov/2021
    Fund Category: Sectoral/ Thematic
    Investment Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
    Fund Description: An open ended equity scheme investing in Pharma and Healthcare
    Fund Benchmark: Nifty Healthcare Total Return Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.